What is the most recent earnings date for ETON stock?
ETON PHARMACEUTICALS INC (ETON) last reported earnings on 3/19/2026.
NASDAQ:ETON • US29772L1089
Past quarterly earnings results for ETON PHARMACEUTICALS INC (ETON), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | 0.06 | 0.09 | -34.64% | 400.00% | 21.281M | 20.991M | 1.38% | 82.72% |
| Q3 2025 | -0.07 | 0.09 | -176.25% | -333.33% | 22.459M | 20.883M | 7.55% | 117.54% |
| Q2 2025 | -0.10 | -0.04 | -167.36% | 16.67% | 18.928M | 17.046M | 11.04% | 108.60% |
| Q1 2025 | 0.07 | 0.05 | 28.68% | 333.33% | 17.282M | 15.434M | 11.97% | 116.95% |
| Q4 2024 | -0.02 | 0.00 | -488.82% | 77.78% | 11.647M | 10.741M | 8.43% | 59.26% |
| Q3 2024 | 0.03 | -0.01 | 394.12% | 250.00% | 10.324M | 9.889M | 4.40% | 46.90% |
| Q2 2024 | -0.12 | -0.07 | -68.07% | -180.00% | 9.074M | 8.976M | 1.09% | -24.36% |
| Q1 2024 | -0.03 | -0.05 | 34.64% | 70.00% | 7.966M | 8.16M | -2.38% | 50.19% |
| Q4 2023 | -0.09 | -0.04 | -120.59% | -325.00% | 7.313M | 7.854M | -6.89% | -13.96% |
| Q3 2023 | -0.02 | -0.10 | 80.39% | 83.33% | 7.028M | 6.384M | 10.09% | 118.26% |
| Q2 2023 | 0.15 | -0.09 | 263.40% | 350.00% | 11.997M | 6.639M | 80.70% | 63.00% |
| Q1 2023 | -0.10 | -0.14 | 29.97% | 52.38% | 5.304M | 4.647M | 14.14% | 143.30% |
| Q4 2022 | 0.04 | 0.01 | 292.16% | - | 8.5M | 9.301M | -8.61% | 39.57% |
| Q3 2022 | -0.12 | -0.15 | 21.57% | 50.00% | 3.22M | 3.11M | 3.54% | 312.82% |
| Q2 2022 | -0.06 | 0.03 | -296.08% | 40.00% | 7.36M | 7.92M | -7.07% | 139.74% |
| Q1 2022 | -0.21 | -0.08 | -157.35% | -210.53% | 2.18M | 7.242M | -69.90% | -81.68% |
| Q4 2021 | 0.04 | 0.19 | -79.36% | 112.50% | 6.09M | 12.768M | -52.30% | 7,512.50% |
| Q3 2021 | -0.24 | -0.14 | -74.29% | 22.58% | 780K | 3.102M | -74.85% | 587.50% |
| Q2 2021 | -0.10 | -0.14 | 29.97% | 56.52% | 3.07M | 3.887M | -21.02% | 15,250.00% |
| Q1 2021 | 0.19 | 0.19 | -1.96% | 138.00% | 11.9M | 12.295M | -3.21% | 11,800.00% |
| Q4 2020 | -0.32 | -0.27 | -20.66% | - | 80K | 1.361M | -94.12% | - |
| Q3 2020 | -0.31 | -0.26 | -19.97% | - | -160K | 1.519M | -110.53% | - |
| Q2 2020 | -0.23 | -0.27 | 13.27% | - | 20K | 300.217K | -93.34% | - |
| Q1 2020 | -0.50 | -0.23 | -119.49% | - | 100K | 1.545M | -93.53% | - |
Notes
ETON PHARMACEUTICALS INC (ETON) last reported earnings on 3/19/2026.
ETON PHARMACEUTICALS INC (ETON) missed EPS estimates and beat revenue estimates in the most recent quarter.
In the last 4 quarters, ETON PHARMACEUTICALS INC (ETON) has beaten EPS estimates in 1 out of 4 releases.